← Scroll for more →
Anika Therapeutics, Inc. (ANIK)
Surgical & Medical Instruments & Apparatus
Latest Price
$19.66
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
10.32
P/B Ratio
1.91
Valuation metrics
adjust assumptions →Base FCF: $4M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$7.01
64% downside
Institutional Ownership
87.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1.45M | $21.0M | 10.83% | -145.2K | 2026-06-30 |
| Caligan Partners LP | 1.44M | $20.0M | 10.72% | -- | 2026-06-30 |
| Morgan Stanley | 614.3K | $8.0M | 4.59% | -257.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 572.1K | $8.0M | 4.27% | -33.7K | 2026-06-30 |
| AQR Capital Management LLC | 559.8K | $8.0M | 4.18% | +287.6K | 2026-06-30 |
| Boothbay Fund Management, LLC | 529.6K | $7.0M | 3.96% | +137 | 2026-06-30 |
| Renaissance Technologies LLC | 481.4K | $7.0M | 3.60% | -20.8K | 2026-06-30 |
| Dimensional Fund Advisors LP | 451.1K | $6.0M | 3.37% | -7.8K | 2026-06-30 |
| Capital Management Corp | 448.5K | $6.0M | 3.35% | +753 | 2026-06-30 |
| Deutsche Bank AG\ | 353.6K | $5.0M | 2.64% | +378 | 2026-06-30 |